NASDAQ: BRKR
Healthcare · Medical - Devices
After hours: $59.27(0%) · as of 7:51 PM ET
Market Cap
$9.02B
52w High
$65.30
52w Low
$28.53
P/E
-84.79
Volume
2.19M
Outstanding Shares
152.23M
Price vs Fundamentals
The stock rose 83.16% over the last year. Revenue grew 1.65% over the trailing twelve months. Operating margin moved from 5.34% to 3.61%. Free cash flow grew 90.47% over the trailing twelve months.
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
Operating margin currently stands at 3.61%. A decisive move in revenue — currently up 1.65% — would be the clearest signal to resolve the ambiguity.
Company profile
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
17
Buy
14
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 2, 2026
Q4 FY26 · EPS est $0.42 · Revenue est $867.35M
View
Dividends
$0.20/shareQuarterly9yr growth streakStretchedBRKR pays a dividend with a 0.34% dividend yield, 9 consecutive years of growth, growing at 4.56% annually, covered 0.6× by free cash flow.
Dividend Yield
0.34%
Annual Div / Share
$0.20
5yr CAGR
+4.56%
Doubles every ~15.5yr
Payout Ratio
—
Stretched
Dividend Growth Rate
3yr CAGR
+0%
5yr CAGR
+4.56%
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$0/mo
In 5 yrs
$0/mo
In 10 yrs
$0/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$3/yr $0/mo | $4/yr+25% $0/mo | $5/yr+56% $0/mo |
Yield-on-cost grows from 0.34% → 0.53% over 10yr
Analysis
No strong strength signal stands out from the latest period pair.
Dividend exceeds free cash flow
Free cash flow covers only 0.61× the dividend. The company is paying out more than it generates in cash, which is unsustainable without borrowing or asset sales.